Mount Yale Investment Advisors, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$6,0008330.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
HARBOR CAPITAL ADVISORS, INC. 147,732$117,1510.02%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders